Zentrale Einrichtungen des Universitätsklinikums Erlangen

Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data (2025) Sponfeldner M, Dürr P, Lensker P, Geßner K, Cuba L, Fietkau R, Neurath M, et al. Journal article Basic versus Complex Arteriovenous Loop Positions in Reconstructive Free Flap Surgery: An Outcome Analysis Focusing on the Antithrombotic Treatment Regimen (2025) Geierlehner A, Hirtreiter J, Lang W, Rother U, Ströbel A, Horch RE, Arkudas A Journal article Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial (2025) Fietkau R, Ghadimi M, Grützmann R, Wittel UA, Jacobasch L, Uhl W, Croner RS, et al. Journal article Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article Patientenorientierte Lehrformate in der Klinischen Pharmazie – zum Status quo in der deutschen universitären Apothekerausbildung (2025) Dörje F, Gnadt M, Bauer J, Dircks M Journal article Recommendations on standard concentrations for continuous infusion of medicinal products in intensive care units Empfehlungen zu Standardkonzentrationen für die kontinuierliche Infusion von Arzneimitteln auf Intensivstationen (2025) Kreysing L, Hilgarth H, Bodenstein M, Haake N, Kaltwasser A, Köck J, Meyn D, et al. Journal article 8. Ringversuch Arzneimittelinformation der ADKA (2025) Strobach D, Hehr J, Klausner S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial. (2025) Plechschmidt J, Fietkau K, Hepp T, Dietrich P, Fischer S, Krebs S, Neurath M, et al. Journal article Shortage of antiseizure medication in Germany: How big is the problem? (2025) Steidl J, Krebs S, Kostev K, Schwab S, Hamer H Journal article Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study (2024) Fischer S, Donhauser M, Cohnen SE, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, et al. Journal article